IBDEI0YD ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17074,1,1,0)
 ;;=1^J1442
 ;;^UTILITY(U,$J,358.3,17074,1,3,0)
 ;;=3^Filgrastim (g-csf) 1mcg
 ;;^UTILITY(U,$J,358.3,17075,0)
 ;;=J1446^^109^1068^46^^^^1
 ;;^UTILITY(U,$J,358.3,17075,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17075,1,1,0)
 ;;=1^J1446
 ;;^UTILITY(U,$J,358.3,17075,1,3,0)
 ;;=3^Tho-Filgastrim 5mcg
 ;;^UTILITY(U,$J,358.3,17076,0)
 ;;=J7050^^109^1068^36^^^^1
 ;;^UTILITY(U,$J,358.3,17076,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17076,1,1,0)
 ;;=1^J7050
 ;;^UTILITY(U,$J,358.3,17076,1,3,0)
 ;;=3^Normal Saline, 250ml
 ;;^UTILITY(U,$J,358.3,17077,0)
 ;;=J7030^^109^1068^35^^^^1
 ;;^UTILITY(U,$J,358.3,17077,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17077,1,1,0)
 ;;=1^J7030
 ;;^UTILITY(U,$J,358.3,17077,1,3,0)
 ;;=3^Normal Saline, 1000ml
 ;;^UTILITY(U,$J,358.3,17078,0)
 ;;=J2405^^109^1068^40^^^^1
 ;;^UTILITY(U,$J,358.3,17078,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17078,1,1,0)
 ;;=1^J2405
 ;;^UTILITY(U,$J,358.3,17078,1,3,0)
 ;;=3^Ondansetron HCL 1mg
 ;;^UTILITY(U,$J,358.3,17079,0)
 ;;=J3489^^109^1068^48^^^^1
 ;;^UTILITY(U,$J,358.3,17079,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17079,1,1,0)
 ;;=1^J3489
 ;;^UTILITY(U,$J,358.3,17079,1,3,0)
 ;;=3^Zoledronic Acid 1mg
 ;;^UTILITY(U,$J,358.3,17080,0)
 ;;=J1815^^109^1068^23^^^^1
 ;;^UTILITY(U,$J,358.3,17080,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17080,1,1,0)
 ;;=1^J1815
 ;;^UTILITY(U,$J,358.3,17080,1,3,0)
 ;;=3^Insulin per 5 units
 ;;^UTILITY(U,$J,358.3,17081,0)
 ;;=J2353^^109^1068^38^^^^1
 ;;^UTILITY(U,$J,358.3,17081,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17081,1,1,0)
 ;;=1^J2353
 ;;^UTILITY(U,$J,358.3,17081,1,3,0)
 ;;=3^Octreotide IM 1mg
 ;;^UTILITY(U,$J,358.3,17082,0)
 ;;=J2354^^109^1068^39^^^^1
 ;;^UTILITY(U,$J,358.3,17082,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17082,1,1,0)
 ;;=1^J2354
 ;;^UTILITY(U,$J,358.3,17082,1,3,0)
 ;;=3^Octreotide SQ/IV 1mg
 ;;^UTILITY(U,$J,358.3,17083,0)
 ;;=J8540^^109^1068^9^^^^1
 ;;^UTILITY(U,$J,358.3,17083,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17083,1,1,0)
 ;;=1^J8540
 ;;^UTILITY(U,$J,358.3,17083,1,3,0)
 ;;=3^Dexamethasone,Oral,25mg
 ;;^UTILITY(U,$J,358.3,17084,0)
 ;;=90471^^109^1069^1^^^^1
 ;;^UTILITY(U,$J,358.3,17084,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17084,1,1,0)
 ;;=1^90471
 ;;^UTILITY(U,$J,358.3,17084,1,3,0)
 ;;=3^Immunization Admin,1 Vaccine
 ;;^UTILITY(U,$J,358.3,17085,0)
 ;;=90472^^109^1069^2^^^^1
 ;;^UTILITY(U,$J,358.3,17085,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17085,1,1,0)
 ;;=1^90472
 ;;^UTILITY(U,$J,358.3,17085,1,3,0)
 ;;=3^Immunization Admin,Ea Addl Vaccine
 ;;^UTILITY(U,$J,358.3,17086,0)
 ;;=90658^^109^1070^1^^^^1
 ;;^UTILITY(U,$J,358.3,17086,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17086,1,1,0)
 ;;=1^90658
 ;;^UTILITY(U,$J,358.3,17086,1,3,0)
 ;;=3^Flu Vaccine
 ;;^UTILITY(U,$J,358.3,17087,0)
 ;;=90632^^109^1070^2^^^^1
 ;;^UTILITY(U,$J,358.3,17087,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17087,1,1,0)
 ;;=1^90632
 ;;^UTILITY(U,$J,358.3,17087,1,3,0)
 ;;=3^Hepatitis A Vaccine
 ;;^UTILITY(U,$J,358.3,17088,0)
 ;;=90636^^109^1070^3^^^^1
 ;;^UTILITY(U,$J,358.3,17088,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17088,1,1,0)
 ;;=1^90636
 ;;^UTILITY(U,$J,358.3,17088,1,3,0)
 ;;=3^Hepatitis A & B Vaccine
 ;;^UTILITY(U,$J,358.3,17089,0)
 ;;=90746^^109^1070^4^^^^1
 ;;^UTILITY(U,$J,358.3,17089,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17089,1,1,0)
 ;;=1^90746
 ;;^UTILITY(U,$J,358.3,17089,1,3,0)
 ;;=3^Hepatitis B Vaccine
 ;;^UTILITY(U,$J,358.3,17090,0)
 ;;=90732^^109^1070^5^^^^1
 ;;^UTILITY(U,$J,358.3,17090,1,0)
 ;;=^358.31IA^3^2
